A RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE III STUDY EVALUATING EFFICACY AND SAFETY OF MOSUNETUZUMAB IN COMBINATION WITH POLATUZUMAB VEDOTIN IN COMPARISON WITH RITUXIMAB IN COMBINATION WITH GEMCITABINE PLUS OXALIPLATIN IN PARTICIPANTS WITH RELAPSED OR REFRACTORY AGGRESSIVE

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2022
This article has no abstract
Epistemonikos ID: 334285878ec784df9b85f9ce705c315b55883e85
First added on: Apr 11, 2025